Drug intelligence / Profile preview

Tringasav

Development stage: Unknown
Lead developer: Mpil Wellness
Modality: Small Molecules
Administration: Oral

Overview

Tringasav is an Ayurvedic herbal supplement developed and marketed by Mpil Wellness (Maheshwari Pharmaceuticals India Limited). Formulated as an oral syrup, it contains a complex blend of over 25-30 traditional Ayurvedic herbs and minerals, including Draksha (Vitis vinifera), Khajoor, Bhringraj, Punarnava, and Loha Bhasma (iron oxide). It is primarily indicated for digestive health, specifically targeting loss of appetite, acidity, constipation, and gas. The supplement functions as a holistic digestive tonic that stimulates the digestive system, enhances nutrient absorption, and helps balance the Pitta dosha according to Ayurvedic principles. Additionally, it is used to address iron deficiency (anemia), general weakness, and certain respiratory conditions.

Brand names: Tringasav

Beyond the preview

Go deeper on Tringasav.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tringasav.

Explore the full profile